Mahoney Stephen F. has filed 9 insider transactions across 1 company since September 2024.
Most recent transaction: a tax payment of 7408 shares of Viridian Therapeutics, Inc.\DE ($VRDN) on March 03, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | F | Common Stock | 7408 | $30.19 | 33,349.0000 | 95,442,008 | 18.18% | 0.01% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | M | Restricted Stock Units | 18357 | $0.00 | 55,071.0000 | 95,442,008 | 25.00% | 0.02% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | F | Common Stock | 7627 | $29.32 | 33,130.0000 | 95,442,008 | 18.71% | 0.01% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | A | Stock Option (Right to Buy) | 559600 | $0.00 | 559,600.0000 | 95,442,008 | 9999.99% | 0.59% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | A | Restricted Stock Units | 111900 | $0.00 | 111,900.0000 | 95,442,008 | 9999.99% | 0.12% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | M | Common Stock | 18357 | $0.00 | 40,757.0000 | 95,442,008 | 81.95% | 0.02% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | A | Restricted Stock Units | 73428 | $0.00 | 73,428.0000 | 81,484,950 | 9999.99% | 0.09% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | A | Stock Option (Right to Buy) | 440565 | $0.00 | 440,565.0000 | 81,484,950 | 9999.99% | 0.54% |
| Sept. 27, 2024 | Viridian Therapeutics, Inc.\DE | $VRDN | Mahoney Stephen F. | President and CEO | P | Common Stock | 21400 | $23.33 | 21,400.0000 | 0 | 9999.99% | 0.00% |